一项关于大剂量免疫球蛋白与单克隆抗体用于挽救激素抵抗性排斥反应的随机前瞻性研究的初步结果。 - Suppr | 超能文献

Preliminary results from a randomized and prospective study of high-dose immunoglobulin versus monoclonal antibody in the rescue of steroid-resistant rejections.

作者信息

Casadei D, Rial M, Argento J, Goldberg J, Raimondi E

机构信息

Instituto de Nefrologia, Buenos Aires, Argentina.

出版信息

Transplant Proc. 1998 Aug;30(5):2164. doi: 10.1016/s0041-1345(98)00575-2.

DOI:10.1016/s0041-1345(98)00575-2

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Preliminary results from a randomized and prospective study of high-dose immunoglobulin versus monoclonal antibody in the rescue of steroid-resistant rejections.一项关于大剂量免疫球蛋白与单克隆抗体用于挽救激素抵抗性排斥反应的随机前瞻性研究的初步结果。

Transplant Proc. 1998 Aug;30(5):2164. doi: 10.1016/s0041-1345(98)00575-2.

2

Treatment of acute kidney allograft rejection with the nonmitogenic CD3 mAb CLB T3/4.A (IgA-CD3): absence of a correlation of clinical responsiveness with inhibition of lymphocyte reactivity in vitro.使用非促有丝分裂性CD3单克隆抗体CLB T3/4.A（IgA-CD3）治疗急性肾移植排斥反应：临床反应性与体外淋巴细胞反应性抑制之间不存在相关性。

Transplant Proc. 2001 Feb-Mar;33(1-2):1229-30. doi: 10.1016/s0041-1345(00)02399-x.

3

Individualized T cell monitored administration of ATG versus OKT3 in steroid-resistant kidney graft rejection.在激素抵抗性肾移植排斥反应中，个体化T细胞监测下抗胸腺细胞球蛋白与OKT3的给药比较

Clin Transplant. 2003 Feb;17(1):69-74. doi: 10.1034/j.1399-0012.2003.02105.x.

4

Clinical and renal histologic predictors of long-term outcome after OKT3 therapy for steroid-resistant rejection.

Transplant Proc. 1995 Feb;27(1):1014-5.

5

Role of cyclosporine rescue therapy in steroid resistant rejections.环孢素挽救疗法在激素抵抗性排斥反应中的作用。

Transplant Proc. 1994 Oct;26(5):2556-7.

6

Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection.半剂量的OKT3在治疗激素抵抗性肾移植排斥反应中有效。

Transplantation. 1996 Jul 15;62(1):38-42. doi: 10.1097/00007890-199607150-00008.

7

ATG versus OKT3 in the treatment of steroid-resistant rejection following living-related donor renal transplantation.抗胸腺细胞球蛋白与OKT3治疗亲属活体供肾移植后激素抵抗性排斥反应的比较

Transplant Proc. 1997 Nov;29(7):2805-6. doi: 10.1016/s0041-1345(97)00686-6.

8

Review and preview of anti-T-cell antibodies.抗T细胞抗体的综述与展望

Transplant Proc. 1995 Oct;27(5 Suppl 1):8-9.

9

Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients.OKT3对肾移植患者类固醇抵抗性急性排斥反应的长期疗效。

Transplant Proc. 1996 Jun;28(3):1354-5.

10

A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection.一项随机前瞻性研究，比较大剂量静脉注射免疫球蛋白与单克隆抗体治疗挽救耐类固醇排斥反应的肾移植的疗效。

Transplantation. 2001 Jan 15;71(1):53-8. doi: 10.1097/00007890-200101150-00009.

引用本文的文献

1

Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.用于治疗肾移植受者急性排斥反应的多克隆抗体和单克隆抗体。

Cochrane Database Syst Rev. 2017 Jul 20;7(7):CD004756. doi: 10.1002/14651858.CD004756.pub4.

2

Cytomegalovirus immune globulin intravenous (human) administration modulates immune response to alloantigens in sensitized renal transplant candidates.静脉注射人巨细胞病毒免疫球蛋白可调节致敏肾移植受者对同种异体抗原的免疫反应。

Clin Exp Immunol. 2000 Mar;119(3):559-65. doi: 10.1046/j.1365-2249.2000.01138.x.